Aguilar-Cordova Estuardo
SEC CIK 1873919 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Dir, 10% | 162.9K | — | $400.3K | 10 | 2021-07-29 | 2025-02-21 |
Most active insiders at CADL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tak Paul Peter | CEO, Dir | — | $3.16M |
| 2 | Manning Paul B | Dir | $3.00M | — |
| 3 | Barone Francesca | CSO | — | $235.8K |
| 4 | Tyagarajan Seshu | CTO | — | $154.2K |
Aguilar-Cordova Estuardo made no open-market trades at CADL in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-21 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $12.02 | -10.6K | 162.9K | -6% | -$127.2K | |
| I | 2025-02-25 | 2025-02-21 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $12.02 | -10.6K | 120.9K | -8% | -$127.2K |
| 2025-02-13 | 2025-02-10 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $8.61 | -31.3K | 60.0K | -34% | -$269.8K | |
| M | 2024-12-13 | 2024-12-11+ | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $9.28 | -400.0K | 473.5K | -46% | -$3.71M |
| MI | 2024-12-13 | 2024-12-11+ | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $9.28 | -400.0K | 631.4K | -39% | -$3.71M |
| M | 2024-10-15 | 2024-10-11+ | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | S - Sale | $6.03 | -40.4K | 919.5K | -4% | -$243.8K |
| M | 2024-10-03 | 2024-10-01+ | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | 10% | S - Sale | $6.93 | -22.6K | 961.7K | -2% | -$156.5K |
| D | 2022-05-10 | 2022-05-06 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | Dir, 10% | M - OptEx | $1.46 | +135.2K | 1.15M | +13% | +$197.4K |
| D | 2022-05-10 | 2022-05-06 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | Dir, 10% | F - Tax | $3.65 | -54.1K | 1.10M | -5% | -$197.4K |
| D | 2021-08-02 | 2021-07-29 | CADL | Candel Therapeutics, Inc. | Aguilar-Cordova Estuardo | CSO, Dir | C - Cnv Deriv | — | +162.1K | 1.02M | +19% | — |
Purchase Sale Sale after option exercise All abbreviations